-
1 month ago | 
healio.com | Joel M. Gelfand |Stephanie Viguers |Kristen Dowd
ORLANDO — The American Academy of Dermatology annual meeting was packed with “massive advancements” across the field, Joel M. Gelfand, MD, MSCE, chief medical editor of Healio Dermatology, said. In this video, Gelfand draws attention to three presentations that he said particularly stood out.
-
2 months ago | 
healio.com | Gabrielle Capaldo |Kristen Dowd |Joel M. Gelfand |Mark Lebwohl
Key takeaways: Skin diseases, such as psoriasis and hidradenitis suppurativa, bring with them severe cardiovascular risks. Addressing these risks through holistic means, including anti-obesity drugs, may improve health. In honor of American Heart Month, Healio Dermatology interviewed experts and explored the connection between skin disease and heart health.
-
2 months ago | 
healio.com | Joel M. Gelfand |Brittany Weber |Kristen Dowd
Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts. In the last of a three-part edition honoring Heart Month, Gelfand, who is also the James J.
-
2 months ago | 
healio.com | Joel M. Gelfand |Brittany Weber |Kristen Dowd
Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts. In the second of a three-part edition honoring Heart Month, Gelfand, who is also the James J.
-
2 months ago | 
healio.com | Joel M. Gelfand |Brittany Weber |Kristen Dowd
Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts. In the first of a three-part edition honoring Heart Month, Gelfand, who is also the James J.
-
2 months ago | 
jamanetwork.com | Joel M. Gelfand |April W. Armstrong |Henry W. Lim |Steven Feldman
Errors in Abstract, Results, and Table 1 Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis Joel M. Gelfand, MD; April W. Armstrong, MD; Henry W. Lim, MD; Steven R. Feldman, MD, PhD; Sandra M. Johnson, MD; W. C. Cole Claiborne, MD; Robert E. Kalb, MD; Jeannette Jakus, MD; Aaron R. Mangold, MD; R. Hal Flowers, MD; Tina Bhutani, MD; John R. Durkin, MD; Jerry Bagel, MD; Scott Fretzin, MD; Michael P.
-
2 months ago | 
healio.com | Gabrielle Capaldo |Kristen Dowd |Joel M. Gelfand
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The study included patients with cutaneous dermatomyositis and those with muscle involvement. Treatment-emergent adverse events occurred in 80% and 81% of dazukibart 150 mg and 160 mg groups.
-
Jan 22, 2025 | 
dialnet.unirioja.es | Joel M. Gelfand |April Armstrong |Henry Lim |Steven Feldman
Ayuda Buscar en la ayuda Buscar en la ayuda Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical Trial Autores: Joel M. Gelfand, April W. Armstrong, Henry W. Lim, Steven R. Feldman, Sandra M. Johnson, W. C. Cole Claiborne, Robert E. Kalb, Jeannette Jakus, Aaron R. Mangold, R. Hal Flowers, Tina Bhutani, John R. Durkin, Jerry Bagel, Scott Fretzin, Michael P. Sheehan, James Krell, Margo J.
-
Nov 21, 2024 | 
healio.com | Gabrielle Capaldo |Kristen Dowd |Joel M. Gelfand
Joel M. Gelfand, MD, MSCE These topline results are stunning. About 50% achieved PASI 90 at week 16 and about 65% of patients achieved PASI 90 at week 24. This level of efficacy is unparalleled for an oral psoriasis treatment. I also think this is a major medical advance.
-
Nov 7, 2024 | 
healio.com | Joel M. Gelfand |Emma Guttman-Yassky |Kristen Dowd
Read more You've successfully added Dermatitis to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.
